MOORE CAPITAL MANAGEMENT, LP – Blueprint Medicines Corporation Transaction History
MOORE CAPITAL MANAGEMENT, LP portfolio value:
$14.94M
portfolio value
Blueprint Medicines Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 226.78K shares | 14.94M | $65.89 | 226.78K |
| Q1 2022 | share | Decrease | -100.00% | -38.65K shares | -4.14M | $63.88 | 0 |
| Q4 2021 | share | Decrease | -76.58% | -126.41K shares | -12.83M | $109.45 | 38.65K |
| Q3 2021 | share | Decrease | -14.99% | -29.11K shares | -109K | $102.81 | 165.06K |
| Q2 2021 | share | Increase | +66.09% | 77.27K shares | 5.71M | $87.96 | 194.18K |
| Q1 2021 | share | Decrease | -43.10% | -88.54K shares | -11.67M | $97.23 | 116.91K |
| Q4 2020 | share | Increase | +71.71% | 85.80K shares | 11.95M | $112.15 | 205.45K |
| Q3 2020 | share | Increase | +378.61% | 94.65K shares | 9.14M | $92.7 | 119.65K |
| Q2 2020 | share | Increase | 0.00% | 25K shares | 1.95M | $78 | 25K |
| Q1 2018 | share | Decrease | -100.00% | -35K shares | -2.63M | $91.7 | 0 |
| Q4 2017 | share | Increase | 0.00% | 35K shares | 2.63M | $75.41 | 35K |